NYU Researchers Pioneer Noninvasive Radio Frequency Technique to Modulate Deep Brain Activity and Treat Neurological Disorders

NYU researchers develop TRFS, a noninvasive radio frequency method to modulate deep brain cells, offering new hope for treatment-resistant depression and epilepsy.

By: AXL Media

Published: Mar 19, 2026, 4:36 AM EDT

Source: Information for this report was sourced from NYU Langone Health

A New Frontier in Noninvasive Neuromodulation

The treatment of chronic brain disorders has long been caught between the limitations of pharmaceutical intervention and the high risks of invasive neurosurgery. A new study led by Dr. György Buzsáki at NYU Grossman School of Medicine introduces Transcranial Radio Frequency Stimulation (TRFS) as a potent middle ground. Unlike existing methods such as electromagnetic coils or ultrasound, which often struggle to reach deep brain structures or suffer from skull interference, TRFS utilizes radio frequency energy to penetrate biological tissue with high precision. This technique allows clinicians to dial nerve signaling up or down, providing a versatile tool for addressing a global crisis where one in three people is affected by a brain disorder.

Overcoming the Limitations of Existing Tech

Traditional noninvasive brain stimulation has historically faced a "depth-versus-focus" trade-off. Contact-based scalp stimulation lacks the focus to target small regions, while magnetic pulses decay too quickly to reach deep neural circuits. To bypass these hurdles, the NYU team engineered customized antennae from the tips of coaxial cables, capable of directing high-frequency signals to specific deep-brain locations. This energy creates localized heat within a safe, healthy range, which in turn alters the flow of charged ions in and out of neurons. This thermal mechanism allows TRFS to achieve a level of depth and specificity previously only possible through implanted electrodes.

The Power of the Pristine Mode

The researchers identified a "pristine mode" for TRFS, which targets the brain's natural inhibitory interneurons. These specialized cells act as the "brakes" of the neural system, sculpting thoughts and perceptions by connecting different circuits. The study found that applying RF energy to these interneurons raised their temperature slightly, leading to a dose-dependent suppression of their activity. This finding is particularly significant because the suppression of these specific cells has been clinically linked to the relief of chronic pain, anxiety, and depression. By modulating these "brakes," TRFS can effectively recalibrate brain circuits that have become overactive due to disease.